Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro
Open Access
- 16 October 2002
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 46 (10) , 2648-2657
- https://doi.org/10.1002/art.10531
Abstract
Objective Osteoarthritic (OA) cartilage destruction depends on collagen- and aggrecan-degrading proteases such as collagenases (MMP-1 and MMP-13), stromelysin (MMP-3), MMP-14, as well as the so-called aggrecanases (ADAM-TS4 and ADAM-TS5). In this study, we tried to clarify whether these proteases are expressed in vivo in human normal and OA cartilage (and whether they are up-regulated or down-regulated during the disease process) and in interleukin-1β (IL-1β)–stimulated chondrocytes in vitro. Methods Quantitative polymerase chain reaction assays were developed and performed on RNA isolated directly from normal and degenerative cartilage tissue as well as from primary human articular chondrocytes cultured with and without IL-1β. Results In vivo, MMP-1 was detectable only at very low levels in any condition. MMP-13 expression was low in normal and early degenerative cartilage but was strongly up-regulated in late-stage OA specimens. MMP-1 and MMP-13 were expressed much higher in vitro than in vivo and were up-regulated by IL-1β. Among all proteases, MMP-3 was by far the most strongly expressed, although it was strongly down-regulated in late-stage OA specimens. Expression of MMP-3 was higher in vitro than in vivo and was up-regulated by IL-1β. ADAM-TS5 and MMP-14 were expressed in all sample groups. Expression of ADAM-TS4 was very low in vivo and was induced in vitro after stimulation by IL-1β. Conclusion Our expression data clearly support MMP-13 as the major collagenase in OA cartilage. The most strongly expressed aggrecanase was ADAM-TS5. ADAM-TS4 was expressed only at a very low level in normal cartilage and was only slightly up-regulated in OA cartilage, casting doubt on this enzyme being the relevant aggrecanase of articular cartilage. Results of our study show that expression of many enzymes is significantly different in vitro and in vivo and suggest that IL-1β stimulation of articular chondrocytes might not be a good model for the matrix catabolism in OA cartilage.Keywords
This publication has 52 references indexed in Scilit:
- Isolation of RNA from small human articular cartilage specimens allows quantification of mRNA expression levels in local articular cartilage defectsJournal of Orthopaedic Research, 2001
- Expression of ADAMTS Homologues in Articular CartilageBiochemical and Biophysical Research Communications, 1999
- Osteoarthritic Lesions. Involvement of three different collagenasesArthritis & Rheumatism, 1997
- Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage.Journal of Clinical Investigation, 1997
- Aggrecan is degraded by matrix metalloproteinases in human arthritis. Evidence that matrix metalloproteinase and aggrecanase activities can be independent.Journal of Clinical Investigation, 1996
- The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. A role in osteoarthritis.Journal of Clinical Investigation, 1996
- Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage.Journal of Clinical Investigation, 1996
- Expression of c‐fos, c‐jun, jun‐B, metallothionein and metalloproteinase genes in human chondrocyteFEBS Letters, 1992
- Preferential mRNA expression of prostromelysin relative to procollagenase and in situ localization in human articular cartilage.Journal of Clinical Investigation, 1992
- Stimulation of procollagenase synthesis parallels increases in cellular procollagenase mRNA in human articular chondrocytes exposed to recombinant interleukin 1β or phorbol esterBiochemical and Biophysical Research Communications, 1987